Recent Security Class Actions

Eagle Pharmaceuticals Inc. Common Stock (NASDAQ: EGRX)

Company Name:Eagle Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: EGRX
Class Period Start:08/08/2023
Class Period End (inclusive):11/28/2023
Filing Deadline:02/09/2024

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that the Company was experiencing slower-than-anticipated pull-though from a wholesale customer predominantly due to expiry of inventory; (2) that, as a result, the Company had overstated its revenue; (3) that the Company did not have effective internal controls and procedures over financial reporting as to PEMFEXY sales; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.